MedEquity Capital Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, MedEquity Capital has invested in 1 company.

MedEquity Capital’s most common sectors for investment arehealthcare services (62%) and medical products (16%) . The Firm’s most common investment types include recapitalization (39%) and buyout (lbo, mbo, mbi) (39%). In total, MedEquity Capital has invested in 10 US states. Its largest (disclosed) acquisition occurred in 2001 when it acquired Heartlab for $23M.

The Firm’s most common exit type is trade sale (88%). MedEquity Capital’s largest (disclosed) exit occurred in 2005 when it sold Heartlab for $133M.

Join Mergr to view MedEquity Capital’s full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity21
    • M&A Buy Activity13
    • M&A Sell Activity8
  • Total Sectors Invested 4
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 16

MedEquity Capital

16 Laurel Avenue, Suite 200,
Wellesley Hills, Massachusetts 02481
United States
(781) 237-6910
www.medequity.com
info@medequity.com

MedEquity Capital LLC is a specialist private equity firm that invests in mid- to late-stage healthcare service and product companies. MedEquity's focus within healthcare services includes provider based services, out-sourced non-core services, infrastructure-focused businesses, product companies with low technology risk, and technology driven service companies. MedEquity will consider both control and non-control investments and looks invest between $2 and $20million per transaction. Investment funds are typically used to support recapitalizations, acquisitions, and growth. MedEquity Capital LLC was formed in 2002 and is based in Wellesley Hills, Massachusetts.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products, Retail, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 2 20
Target EBITDA 1 4
Investment Size 2 20
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 12 - - 1 - - 13
vol $49M $49M
Sell (0.0/yr) # 8 - - - - - 8
vol $296M $296M
  21

Most Recent M&A

Company Date Value Type
Riverside Oral Surgery Management, LLC 2022-12-19 - Stake Purchase
River Edge, New Jersey · www.riversideoralsurgery.com
Belmar Pharma Solutions 2019-04-22 - Buyout (LBO, MBO, MBI)
Golden, Colorado · www.belmarpharmasolutions.com
PharmaLogic Holdings LLC 2015-09-16 - Recapitalization
Boca Raton, Florida · www.radiopharmacy.com
Tristan Medical Care Centers 2014-07-01 - Recapitalization
Brockton, Massachusetts · www.tristanmed.com
LiceGuard LLC 2012-12-12 - Add-on Acquisition
Needham, Massachusetts · www.liceguard.com
Crescent Healthcare, Inc. 2012-02-14 75M USD Trade Sale
Anaheim, California · www.crescenthealthcare.com
EnduraCare Therapy Management, Inc. 2012-01-31 35M USD Trade Sale
Las Vegas, Nevada · www.enduracare.com
VelQuest Corp. 2011-12-30 35M USD Trade Sale
Hopkinton, Massachusetts · www.velquest.com
AppleCare Immediate Care 2011-09-10 - Recapitalization
Savannah, Georgia · www.applecaredoctors.com
EnduraCare Acute Care Services, LLC 2009-10-12 - Recapitalization
Franklin, Tennessee · www.enduracareac.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
PharmaLogic Holdings LLC 2015-09-16 Lantheus' Puerto Rico Radiopharmacy and PET Manufacturing Facility 2020-12-03 1
Boca Raton, Florida · www.radiopharmacy.com San Juan, Puerto Rico

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 5 (71%) - 8 (62%) 12M (24%)
Medical Products 1 (14%) - 2 (15%) 23M (47%)
Software - - 2 (15%) 14M (29%)
Consumer Products 1 (14%) - 1 (8%) -
Total 7 - 13 $49M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 7 (100%) - 13 (100%) 49M (100%)
  Massachusetts 2 (29%) - 2 (15%) -
  Florida 1 (14%) - 2 (15%) 14M (29%)
  Colorado 1 (14%) - 2 (15%) 12M (24%)
  New Jersey 1 (14%) - 1 (8%) -
  Georgia 1 (14%) - 1 (8%) -
  Tennessee 1 (14%) - 1 (8%) -
  Rhode Island - - 1 (8%) 23M (47%)
  Nevada - - 1 (8%) -
  California - - 1 (8%) -
  Ohio - - 1 (8%) -
Total 7 - 13 $49M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 1 (14%) - 5 (38%) 49M (100%)
Recapitalization 4 (57%) - 5 (38%) -
Add-on Acquisition 1 (14%) - 1 (8%) -
Stake Purchase 1 (14%) - 1 (8%) -
Venture - - 1 (8%) -
Total 7 - 13 $49M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 5 (63%) 261M (88%)
Trade Sale 2 (25%) 35M (12%)
Secondary Sale 1 (13%) -
Total 8 $296M

Deal Values

buy # Total
< $100M 3 $49M
TOTAL $49M
Largest Heartlab, Inc.
$23M (2001-04-30)
sell # Total
$100M to $1B 1 $133M
< $100M 4 $163M
TOTAL $296M
Largest Heartlab, Inc.
$133M (2005-04-19)

M&A Connections

Deals
Exited to
Investor(s)
13%
1 (13%)
Strategic(s)
88%
7 (88%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

Established

1999

Specialist/Generalist

Specialist

Leadership

Jeffrey Ward

Co-founder & Partner

W. Brandon Ingersoll

Co-Founder & Partner

Tom Beausejour

Principal

FAQ

When was MedEquity Capital founded?

MedEquity Capital was founded in 1999.

What type of investor is MedEquity Capital?

MedEquity Capital is a private equity firm.

Where is MedEquity Capital headquartered?

MedEquity Capital is headquartered in Wellesley Hills, Massachusetts.

 Subscribe to unlock this and 200,109
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 191K M&A Transactions
  • 196K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal